Select Committee on Public Accounts Second Report

List of written evidence

---

1  American Pharmaceuticals Group  Ev 13

2  Merck, Sharp and Dohme  Ev 15

3  Sanofi-Aventis & Bristol-Myers Squibb Pharmaceuticals Ltd  Ev 16, 17

4  W. A. Smith  Ev 17

---

---

Prepared 17 January 2008